]>
IRCT2015122025622N1 IRCT 2016-05-29 Vice chancellor for research,Mashhad University of Medical Sciences evaluation of an ITM – based protocol on clinical improvement of CVA CVA:cerebro vascular attack Explanation of cerebrovascular attack (CVA) based on Iranian traditional medicine (ITM) and evaluation of clinical trial an ITM – based protocol and modern medical- based protocol on clinical improvement of CVA 2016-06-04 anticipated 80 Complete https://irct.ir/trial/21389 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: In this randomized study is done based on random numbers table. 2 Ischemic cerebro vascular attack. Intervention 1: The intervention group, in addition to the current anti-ischemic drugs, ITM, based protocol will be prescribed. - Traditional Therapy package includes an oral syrup safflower extract and safflower oil is a nasal drop. Venice is a barley soup (including barley, celery, prune, tamarind, candy and a little salt and turmeric) is included in the patient's diet - dose nasal drops 3 drops in each nostril every 4 hours Mybashd.bh a month - barley soup In the first two weeks the patient will be referred to the main course. A 100 ml bottle of safflower syrup prepared with a concentration of 25% by volume weight twice daily to patients is recommended every 5 ml of the syrup mill. For a month. Intervention 2: Routin anti-ischemic drugs plus a placebo given to the control group. Current treatments include aspirin 325 mg daily, and 20 mg Trvstatyn and, if not above the patient's creatinine is 30 cc daily Piracetam. Inert placebo form of the drug is similar to the intervention group.
public Delshad Elahe
opposite the Mehran sports hall, East Razi Street, Dahe day Square
Mashhad Iran (Islamic Republic of) +98 51 3855 2188 delshade911@mums.ac.ir Mashhad University of Medical Sciences scientific Delshad Elahe
opposite of the Mehran sports hall, East Razi Street, dahe day Square
Mashhad Iran (Islamic Republic of) +98 51 3732 7620 delshade911@mums.ac.ir Mashhad University of Medical Sciences Iran (Islamic Republic of) In our study, the inclusion criteria encompassed patients whom were discovered to have focal neurological symptoms after their brain imaging, being diagnosed with ischemic CVA. On the other hand, the exclusion criteria were as follows: 1. patients with focal neurological findings ith regard to the candidate symptoms of venous rTPA; 2. patients with symptoms in less than 24 hours of a TIA with normal imaging raises; 3. patients on admission with NIHSS Score and analytically based on a bad prognosis. 4. patients with chronic systemic diseases such as uremia, chronic liver disease, and high blood pressure a potential impact would be on our protocol and our intervention would accelerate HIV disease; 6. patients with possible teratogenic effects of safflower pregnancy; 7. patients having any evidence of brain hemorrhage; 8. patients receiving anticoagulant (heparin or warfarin); 9. incidence of venous infarcts in venous sinus thrombosis; 10. patients reluctant to continue double-blind treatment. During hospitalization, the patients were visited on a daily basis by experts who closely supervised the treatment. no limit no limit Both G46.4* cerebro vascular syndrom Treatment - Drugs Treatment - Drugs The intervention group, in addition to the current anti-ischemic drugs, ITM, based protocol will be prescribed. - Traditional Therapy package includes an oral syrup safflower extract and safflower oil is a nasal drop. Venice is a barley soup (including barley, celery, prune, tamarind, candy and a little salt and turmeric) is included in the patient's diet - dose nasal drops 3 drops in each nostril every 4 hours Mybashd.bh a month - barley soup In the first two weeks the patient will be referred to the main course. A 100 ml bottle of safflower syrup prepared with a concentration of 25% by volume weight twice daily to patients is recommended every 5 ml of the syrup mill. For a month Routin anti-ischemic drugs plus a placebo given to the control group. Current treatments include aspirin 325 mg daily, and 20 mg Trvstatyn and, if not above the patient's creatinine is 30 cc daily Piracetam. Inert placebo form of the drug is similar to the intervention group. Score of disability based on Questionnaire NIHSS. Timepoint: Baseline and one month after presentation. Method of measurement: Clinical examination by an expert on the NIHSS score. Biochemical markers. Timepoint: Baseline and one month after the initial visit. Method of measurement: blood test. Vice chancellor for research,Mashhad University of Medical Sciences Approved 2015-12-13 Ethics committee of Mashhad University of Medical Sciences Ghoreshi department, Avenue Daneshgah, Mashhad Mashhad Iran (Islamic Republic of)